EV Nickel Inc. | Finanzwire

Basculer en Français

8306	Companies
115324	Keywords
55596	Articles
62612	Press releases

Home
Companies
EV Nickel Inc.

BRIEF

published on 06/27/2024 at 07:35, 4 months 25 days ago

APONTIS PHARMA AG Appoints CFO Thomas Zimmermann to Management Board

Management Board APONTIS PHARMA ESG Strategy Thomas Zimmermann Single Pill
PRESS RELEASE

published on 06/27/2024 at 07:30, 4 months 25 days ago

APONTIS PHARMA AG appoints CFO Thomas Zimmermann to the Management Board with a view to the strategic development of the Company
APONTIS PHARMA AG appoints CFO Thomas Zimmermann to the Management Board to enhance strategic development, internationalization, and ESG strategy. CFO brings strong financial expertise

CFO Strategic Development Management Board APONTIS PHARMA AG Thomas Zimmermann
BRIEF

published on 06/24/2024 at 11:06, 4 months 28 days ago

APONTIS PHARMA AG Receives Buy Rating from First Berlin Equity Research

BUY Rating APONTIS PHARMA AG Single Pills Turnaround Story Cardiovascular And Respiratory Drugs
PRESS RELEASE

published on 06/24/2024 at 11:01, 4 months 28 days ago

Original-Research: APONTIS PHARMA AG (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research initiates coverage on APONTIS PHARMA AG with a Buy rating and EUR 17.00 price target. Apontis focuses on cardiovascular and respiratory drugs in Germany, led by CEO Wohlschlegel to drive efficiency and growth

First Berlin Equity Research APONTIS PHARMA AG Specialty Pharmaceuticals Turnaround Story Single Pill Therapies
BRIEF

published on 06/17/2024 at 14:43, 5 months 5 days ago

EV Nickel Updates 2024 Exploration Plan, Commences Diamond Drill Program on High-Grade Target

Exploration Diamond Drilling CarLang Trend EV Nickel Nickel Targets
PRESS RELEASE

published on 06/17/2024 at 14:38, 5 months 5 days ago

EV Nickel Provides Update on 2024 Exploration Plan - Initiates Diamond Drill Program on High Grade Target
EV Nickel Inc. (TSX-V:EVNI) provides update on 2024 Exploration Plan, diamond drilling on Langmuir #2 high priority nickel target. Expanding activities on CarLang resource, drilling high-grade targets, advancing clean metal bioleaching program

Diamond Drilling Exploration Plan EV Nickel Inc. Nickel Targets Clean Metal Bioleaching
BRIEF

published on 06/06/2024 at 15:30, 5 months 16 days ago

EV Nickel Identifies Significant Nickel Mineralization Extension Along CarLang Trend

Surface Sampling EV Nickel Inc. Nickel Mineralization CarLang Trend Shaw Dome Project
PRESS RELEASE

published on 06/06/2024 at 15:25, 5 months 16 days ago

EV Nickel Surface Sample Program Identifies Significant Extension Of Large-Scale Nickel Mineralization Along The Carlang Trend
EV Nickel Inc. announces positive assay results from 148 surface samples at the CarLang Trend in its Shaw Dome Project. Potential for large contiguous nickel mineralization. Expansion of sampling program planned

Sampling Program Assay Results EV Nickel Inc. Nickel Mineralization CarLang Trend
BRIEF

published on 06/04/2024 at 07:35, 5 months 18 days ago

APONTIS PHARMA Appoints New Head of Supply Chain to Drive Growth

Growth Supply Chain APONTIS PHARMA Internationalization Mila Brückel
PRESS RELEASE

published on 06/04/2024 at 07:30, 5 months 18 days ago

APONTIS PHARMA continues to gear organization towards growth and internationalization – Renowned industry expert leads supply chain management
APONTIS PHARMA appoints renowned industry expert Mila Brückel as Head of Supply Chain, gearing organization towards growth and internationalization

Pharmaceutical Industry Supply Chain Management APONTIS PHARMA Internationalization Mila Brückel

Accesswire

Published on 11/22/2024 at 16:00, 44 minutes ago

Manimal Tales Unveils Two New Personalized Christmas-Themed Books to Spread Holiday Magic and Joy!
Published on 11/22/2024 at 15:55, 49 minutes ago

Independent Proxy Advisory Firm ISS Recommends Signal Gold Shareholders Vote for Arrangement Resolution and Private Placement Resolution
Published on 11/22/2024 at 15:15, 1 hour 29 minutes ago

Xenetic Biosciences, Inc. Releases Virtual Investor "What This Means" Segment
Published on 11/22/2024 at 14:45, 1 hour 59 minutes ago

Jaguar Health Seeking Partner to Develop and Commercialize NP300 Second-Generation Antisecretory Prescription Drug Candidate for Treatment of General Diarrhea in Dogs
Published on 11/22/2024 at 14:30, 2 hours 14 minutes ago

Allied Universal Named Presenting Sponsor of 2024 Lott IMPACT Trophy Recognizing College Football's Defensive Best

View all ACCESSWIRE

EQS Group

Published on 11/22/2024 at 16:00, 44 minutes ago

Proposed cancellation of admission to trading
Published on 11/22/2024 at 16:00, 44 minutes ago

AlphaX Makes Crypto Easier with Email Login and USDT Memecoins
Published on 11/22/2024 at 15:27, 1 hour 17 minutes ago

EQS-Adhoc: Eckert & Ziegler raises its forecast for the current financial year once again
Published on 11/22/2024 at 14:46, 1 hour 57 minutes ago

Form 8.3 - The Vanguard Group, Inc.: International Paper Company
Published on 11/22/2024 at 14:45, 1 hour 58 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Centamin plc

Les Echos

Published on 11/22/2024 at 14:35, 2 hours 9 minutes ago

Thales Press release
Published on 11/21/2024 at 06:58, 1 day 9 hours ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 1 day 21 hours ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 1 day 22 hours ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 1 day 22 hours ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024

View all LES ECHOS COMFI WIRE